188 related articles for article (PubMed ID: 16552038)
1. Mapping of a domain required for protein-protein interactions and inhibitory activity of a Helicobacter pylori dominant-negative VacA mutant protein.
Torres VJ; McClain MS; Cover TL
Infect Immun; 2006 Apr; 74(4):2093-101. PubMed ID: 16552038
[TBL] [Abstract][Full Text] [Related]
2. A dominant negative mutant of Helicobacter pylori vacuolating toxin (VacA) inhibits VacA-induced cell vacuolation.
Vinion-Dubiel AD; McClain MS; Czajkowsky DM; Iwamoto H; Ye D; Cao P; Schraw W; Szabo G; Blanke SR; Shao Z; Cover TL
J Biol Chem; 1999 Dec; 274(53):37736-42. PubMed ID: 10608833
[TBL] [Abstract][Full Text] [Related]
3. A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation.
McClain MS; Cao P; Iwamoto H; Vinion-Dubiel AD; Szabo G; Shao Z; Cover TL
J Bacteriol; 2001 Nov; 183(22):6499-508. PubMed ID: 11673417
[TBL] [Abstract][Full Text] [Related]
4. Random mutagenesis of Helicobacter pylori vacA to identify amino acids essential for vacuolating cytotoxic activity.
McClain MS; Czajkowsky DM; Torres VJ; Szabo G; Shao Z; Cover TL
Infect Immun; 2006 Nov; 74(11):6188-95. PubMed ID: 16954403
[TBL] [Abstract][Full Text] [Related]
5. Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin.
Cover TL; Krishna US; Israel DA; Peek RM
Cancer Res; 2003 Mar; 63(5):951-7. PubMed ID: 12615708
[TBL] [Abstract][Full Text] [Related]
6. Analysis of a beta-helical region in the p55 domain of Helicobacter pylori vacuolating toxin.
Ivie SE; McClain MS; Algood HM; Lacy DB; Cover TL
BMC Microbiol; 2010 Feb; 10():60. PubMed ID: 20178613
[TBL] [Abstract][Full Text] [Related]
7. A Nonoligomerizing Mutant Form of Helicobacter pylori VacA Allows Structural Analysis of the p33 Domain.
González-Rivera C; Campbell AM; Rutherford SA; Pyburn TM; Foegeding NJ; Barke TL; Spiller BW; McClain MS; Ohi MD; Lacy DB; Cover TL
Infect Immun; 2016 Sep; 84(9):2662-70. PubMed ID: 27382020
[TBL] [Abstract][Full Text] [Related]
8. RACK1 protein interacts with Helicobacter pylori VacA cytotoxin: the yeast two-hybrid approach.
Hennig EE; Butruk E; Ostrowski J
Biochem Biophys Res Commun; 2001 Nov; 289(1):103-10. PubMed ID: 11708784
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence resonance energy transfer microscopy of the Helicobacter pylori vacuolating cytotoxin within mammalian cells.
Willhite DC; Ye D; Blanke SR
Infect Immun; 2002 Jul; 70(7):3824-32. PubMed ID: 12065526
[TBL] [Abstract][Full Text] [Related]
10. Vacuolating cytotoxin A (VacA) - A multi-talented pore-forming toxin from Helicobacter pylori.
Junaid M; Linn AK; Javadi MB; Al-Gubare S; Ali N; Katzenmeier G
Toxicon; 2016 Aug; 118():27-35. PubMed ID: 27105670
[TBL] [Abstract][Full Text] [Related]
11. A Helicobacter pylori vacuolating toxin mutant that fails to oligomerize has a dominant negative phenotype.
Genisset C; Galeotti CL; Lupetti P; Mercati D; Skibinski DA; Barone S; Battistutta R; de Bernard M; Telford JL
Infect Immun; 2006 Mar; 74(3):1786-94. PubMed ID: 16495552
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori vacuolating cytotoxin, VacA.
Hirayama T; Wada A; Yahiro K; Kimura M; Kimura T
Jpn J Infect Dis; 2002 Feb; 55(1):1-5. PubMed ID: 11971154
[TBL] [Abstract][Full Text] [Related]
13. Identification of the Helicobacter pylori VacA toxin domain active in the cell cytosol.
de Bernard M; Burroni D; Papini E; Rappuoli R; Telford J; Montecucco C
Infect Immun; 1998 Dec; 66(12):6014-6. PubMed ID: 9826387
[TBL] [Abstract][Full Text] [Related]
14. Identification of the minimal intracellular vacuolating domain of the Helicobacter pylori vacuolating toxin.
Ye D; Willhite DC; Blanke SR
J Biol Chem; 1999 Apr; 274(14):9277-82. PubMed ID: 10092603
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori VacA subdomain required for intracellular toxin activity and assembly of functional oligomeric complexes.
Ivie SE; McClain MS; Torres VJ; Algood HM; Lacy DB; Yang R; Blanke SR; Cover TL
Infect Immun; 2008 Jul; 76(7):2843-51. PubMed ID: 18443094
[TBL] [Abstract][Full Text] [Related]
16. In search of the Helicobacter pylori VacA mechanism of action.
Papini E; Zoratti M; Cover TL
Toxicon; 2001 Nov; 39(11):1757-67. PubMed ID: 11595638
[TBL] [Abstract][Full Text] [Related]
17. The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity.
Pagliaccia C; de Bernard M; Lupetti P; Ji X; Burroni D; Cover TL; Papini E; Rappuoli R; Telford JL; Reyrat JM
Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10212-7. PubMed ID: 9707626
[TBL] [Abstract][Full Text] [Related]
18. An Overview of Helicobacter pylori VacA Toxin Biology.
Foegeding NJ; Caston RR; McClain MS; Ohi MD; Cover TL
Toxins (Basel); 2016 Jun; 8(6):. PubMed ID: 27271669
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori VacA, a distinct toxin exerts diverse functionalities in numerous cells: An overview.
Chauhan N; Tay ACY; Marshall BJ; Jain U
Helicobacter; 2019 Feb; 24(1):e12544. PubMed ID: 30324717
[TBL] [Abstract][Full Text] [Related]
20. Clustering and redistribution of late endocytic compartments in response to Helicobacter pylori vacuolating toxin.
Li Y; Wandinger-Ness A; Goldenring JR; Cover TL
Mol Biol Cell; 2004 Apr; 15(4):1946-59. PubMed ID: 14742715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
